| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.002 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.003 |